Insulin Secretion in Type Diabetes

In patients with type 2 diabetes, plasma glucose levels are elevated; and consequently, fasting plasma insulin. Although the insulin levels sometimes increase slightly after a meal in patients with type 2 diabetes mellitus this is considerably less than normal. In studies in which glucose levels have been raised by glucose infusions (hyperglycemic clamps) to comparable levels in diabetic subjects and controls, it has become clear that second-phase insulin secretion is roughly 25% (IGT) to 50% decreased in type 2 diabetes (53). First-phase secretion is generally completely lost. In normoglycemic first-degree relatives insulin secretion is also diminished but to a lower extent, presumably on a genetic basis (54). It is suspected that upon acquaintance of insulin resistance (obesity, physical inactivity) the pancreas that has already lower secretory capabilities can adapt less than normal, which might lead to decreased glucose tolerance or diabetes. It has been widely suggested that various mechanisms might further

FIGURE 5 Insulin secretion. Schematic representation of normal glucose-Induced insulin secretion. Abbreviations: ADP, adenosine dephosphate; ATP, adension triphosphate; IAAP, islet amyloid polypeptide.

aggravate beta-cell insulin secretory dysfunction, among which glucose toxicity, lipotoxicity, and amyloid deposition.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment